Want to learn more about the UK's ILAP process and whether it's delivering its intended benefits? Check out this blog where #IQVIA's Sumayya Mushtaq, Jennifer Gaultney, Keith McDonald, take a deep dive and take a look at access to Orbis-Designated Oncology Products within the UK: https://bit.ly/3ZTxeVJ
IQVIA UK and Ireland ’s Post
More Relevant Posts
-
Did your organization apply for the reopened Enhancing Oncology Model (EOM)? In a recent Canopy webinar, thought leaders from CMS and community oncology shared helpful insights and strategies for success in the EOM and other value-based programs. Catch the full discussion to learn more: https://lnkd.in/ekfjd6V4
-
-
Going to EHA 2024? Connect with us to learn more about our tailored reports from the leading source of European oncology data. https://ow.ly/rCCm30sCZRl #EHA2024 #OncologyData #RealWorldResearch
-
-
Vice President Operations @ TriNetX Oncology GmbH ¦ Managing Director @ CancerDataNet GmbH
Going to EHA 2024? Connect with us to learn more about our tailored reports from the leading source of European oncology data. https://ow.ly/CXtg30sCE8F #EHA2024 #OncologyData #RealWorldResearch
-
-
Vice President Operations @ TriNetX Oncology GmbH ¦ Managing Director @ CancerDataNet GmbH
Going to EHA 2024? Connect with us to learn more about our tailored reports from the leading source of European oncology data. https://ow.ly/aLsR30sE7SS #EHA2024 #OncologyData #RealWorldResearch
-
-
Looking for regulatory-grade data based on representative samples of patients and healthcare organizations in each country of scope? TriNetX Oncology’s TherapyMonitor reports could be your solution. Learn more about TriNetX oncology offerings: https://ow.ly/wwpN50R7MS8 #OncologyData #RealWorldEvidence
-
-
Vice President of Client Services | Accelerating the Value of the MEDITECH EHR | Abbott World Marathon Majors Six-Star Finisher
If you are a MEDITECH #Expanse healthcare organization that is considering implementing the Oncology (ONC) module, you owe it to yourself to read this article by Haffty Consulting's own Ann Walsh, a leading clinical consultant with years of ONC experience.
Ann Walsh shared her experience collaborating with clients on implementing MEDITECH’s Oncology solution across platforms and the benefits of MEDITECH Expanse as an Integrated Oncology solution on the Haffty Consulting site at https://lnkd.in/gUAmndgp
-
-
IQVIA’s Early Phase Oncology Network (EPON) is a global network of qualified Phase I oncology sites. By utilizing pre-identified experienced sites, site selection timelines can be reduced, and operational efficiencies increased. Learn more about what makes us different. https://bit.ly/4cruPGv #EarlyPhaseOncology #CancerResearch #ClinicalTrials #OncologyResearch
-
-
In need of #Regulatory-grade EU Oncology data? Let's meet in Madrid at #EHA next month! Please reach out to learn more about our tailored reports and ECA capabilities from the leading source of European oncology data. https://ow.ly/s3Ee30sCAv2 #EHA2024 #OncologyData #RealWorldResearch #Externalcontrolarm
-
-
When was the last time you conducted an Oncology Revenue Cycle Assessment? With an assessment, we can find, fix and fund your oncology revenue cycle problems using our Oncology Revenue Recovery (ORR) process. Find out more about the process here: https://bit.ly/3EZ4xhg
-
-
When was the last time you conducted an Oncology Revenue Cycle Assessment? With an assessment, we can find, fix and fund your oncology revenue cycle problems using our Oncology Revenue Recovery (ORR) process. Find out more about the process here: https://bit.ly/3EZ4xhg
-
